Business
Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook
Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook.
About this update from Glucose Health, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook\r\n \r\n \r\n\r\n\r\nGlucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook\r\n\r\n\r\n\r\n\r\n\r\nBENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of Directors, effective October 20, 2025. The Company also announced the appointment of Marc Hatch as Chief Financial Officer and Chief Operating Officer, effective the same date. Mark Schaftlein is an accomplished small-cap public-company executive and entrepreneur with more than 25 years of leadership experience in U.S. public markets. For two decades, he has served as Chief Executive Officer and in senior officer positions of publicly traded emerging-growth companies, developing a deep understanding of the regulatory and operational complexities facing small issuers. Through his firm, Capital Consulting, Inc., Mr. Schaftlein is one of the core group of investors (see further below) who have committed substantial capital to Glucose Health, Inc. His extensive background in corporate governance, market navigation, and institutional engagement will be instrumental as Glucose Health, Inc. executes its future financing initiatives. Mr. Schaftlein is a graduate of Western Kentucky University’s College of Business. Marc Hatch is a seasoned operations and marketing executive with decades of experience developing, expanding, and managing consumer-facing direct sales and B2B operations. Marc brings a demonstrated history of optimizing sales performance, controlling costs, and enhancing profitability within direct-response and performance-based marketing channels. He has directed large-scale, multi-faceted national campaigns across broadcast, digital, and direct-response platforms. Mr. Hatch also operates Media Funding Group, a private entity specializing in marketing finance, which has committed significant capital to accelerate the ramp-up of the GlucoDown® and Fiber Up® brands. Mr. Hatch is a graduate of the Central Washington University School of Business and Economics (formerly the School of Accounting and Business). Both Mr. Schaftlein and Mr. Hatch bring meaningful investment and long-...